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Abstract. We have recently cloned and characterized a 
human member (BM28) of the MCM2-3-5 family of pu- 
tative replication factors (Todorov, I. T., R. Pepperkok, 
R. N. Philipova, S. Kearsey, W. Ansorge, and D. 
Werner. 1994. J. Cell Sci. 107:253-265).  While this pro- 
tein is located in the nucleus throughout interphase, we 
report here a dramatic alteration in its nuclear binding 
during the cell cycle. BM28 is retained in the nucleus af- 
ter Triton X-100 extraction in G1 and early S phase 
cells, but is progressively lost as S phase proceeds, and 
little BM28 is retained in detergent-extracted G2 nu- 
clei. BM28 that is resistant to extraction in G1 nuclei is 
removed by DNase I digestion, suggesting that the pro- 
tein is chromatin associated. 
In addition, we present evidence for variations in the 
electrophoretic mobility of BM28 that may reflect post- 
translational modifications of BM28 during the cell cy- 
cle. During mitosis, BM28 is present as a fast-migrating 
form, but on entry into G1, the protein is converted 
into a slow-migrating form. With the onset of S phase, 
the slow-migrating form is progressively converted into 
the fast form. BM28 is phosphorylated at all stages of 
the cell cycle, but during interphase the fast form is hy- 
perphosphorylated compared with the slow form. 
These apparent changes in modification may reflect or 
effect changes in the nuclear binding of BM28. 
The behavior of BM28 is not dissimilar to related 
proteins in Saccharomyces cerevisiae, such as Mcm2p, 
which are excluded from the nucleus after DNA repli- 
cation. We speculate that BM28 may be involved in the 
control that limits eukaryotic DNA replication to one 
round per cell cycle. 
S 
TUDIES of chromosomal replication have shown that, in 
many systems, an initiation event at a replication ori- 
gin is followed by a latent period, during which that 
origin is inactive. This is demonstrated clearly in eukaryotic 
cells, where  initiation events,  which  occur  throughout S 
phase,  only take place  on unreplicated  DNA. Replicated 
chromosomes  usually have to pass through mitosis before 
further initiation events can occur, and thus one round of 
replication per cell cycle is ensured (for review see Coverley 
and Laskey, 1994; Diffiey, 1994; Stillman, 1994). The nature 
of the control is not clear but appears to be cis-acting at the 
level of the template, as cell fusion experiments  have indi- 
cated that a G1, but not a G2, nucleus can replicate when 
fused to an S phase cell (Rao and Johnson, 1970). Studies 
on the effects of nuclear permeabilization  on DNA replica- 
tion in Xenopus egg extracts have suggested that G1 but not 
G2 nuclei contain "licensing factor," which acts as a positive 
signal,  permitting  DNA  replication  (Blow  and  Laskey, 
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1988; for review see  Coverley  and Laskey, 1994). In this 
model,  a  hypothetical licensing factor binds  to chromatin 
during mitosis and permits DNA replication during the fol- 
lowing S phase. The licensing factor is inactivated  by the 
passage of the replication fork, excluded from the nucleus, 
and its access to the chromatin is blocked  by the nuclear 
membrane until the following mitosis, thus preventing over- 
replication of DNA during a single cell cycle. 
Evidence  for  a  licensing  factor-based  model  would 
clearly benefit from the identification of a suitable  candi- 
date molecule.  Recently, a  family of proteins has been 
identified in Saccharomyces cerevisiae and other eukary- 
otes that has some of the properties expected of licensing 
factor (for review see Tye, 1994). There are at least five 
distinct  proteins in this family in S.  cerevisiae, of which 
Mcm  1 2p, Mcm3p  (Yan et al., 1991, 1993), and Cdc46p/ 
Mcm5p  (Hennessy et al.,  1990, 1991; Chen et al.,  1992) 
have been studied in most detail. These proteins share ex- 
tensive sequence similarity in a central region, but show 
relatively little similarity in their NH2- and COOH-termi- 
1. Abbreviations  used in this paper:  BrdU, bromodeoxyuridine;  CSK, cy- 
toskeleton;  DAPI, 4,6-Diamino-2-phenylindole;  Mcm, minichromosome 
maintenance;  PCNA, proliferating  cell nuclear antigen; RPA, replication 
protein A. 
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tial, indicating that the proteins cannot substitute for each 
other's activity. Conditional mutants show a cell cycle ar- 
rest in interphase, S phase execution is affected, and the 
ability of replication origins to function is reduced, sug- 
gesting that the initiation step of DNA replication is al- 
tered. Strains bearing the cdc46-1 conditional allele arrest 
with a single genomic equivalent of DNA, suggesting that 
there is a global requirement for Cdc46p in chromosome 
replication (Hennessy et al., 1990, 1991). The biochemical 
function of these proteins is obscure, but they all contain a 
"deviant"  nucleoside  triphosphate  (NTP)-binding  motif 
(Koonin, 1993), suggesting that they may be capable of hy- 
drolyzing NTPs.  Studies  of  the  cellular  localization  of 
these proteins in budding yeast have revealed an interest- 
ing cell cycle alteration, which has led to comparisons with 
hypothetical licensing factor. Mcm2p, Mcm3p (Yan et al., 
1993)  and  Mcm5p/Cdc46p  (Hennessy  et  al.,  1990)  are 
found in the nucleus during the G1 phase, but disappear 
during S phase, and they remain excluded until a late mi- 
totic stage, inviting speculation that disappearance  from 
the  nucleus ensures that there  is  no residual activity to 
promote further DNA replication. 
In addition to S. cerevisiae, relatives of this protein fam- 
ily have been studied in other eukaryotes. In fission yeast, 
three genes in this family, namely, cdc21 ÷ (Nasmyth and 
Nurse, 1981; Coxon et al., 1992),  ndal ÷, and nda4 ÷ (Mi- 
yake et al., 1993), have so far been identified from screens 
for  conditional mutations that  have  a  cell  cycle-arrest- 
phenotype, and each gene may be homologous to a bud- 
ding yeast relative. Strains mutant in these genes are also 
affected in S phase execution, similar to the situation in S. 
cerevisiae. Higher eukaryotic members of this gene family 
have also been discovered, starting with the murine P1 pro- 
tein, closely related to Mcm3p of budding yeast (Thrmmes 
et al., 1992; Hu et al., 1993; Bucci et al., 1993). While this 
manuscript was being prepared, Kimura et al. (1994)  re- 
ported an analysis of the cell cycle changes in the nuclear 
binding and phosphorylation of the P1 protein. 
We  have recently identified a  human member  of the 
family, called  BM28,  which  is  most  closely  related  to 
S. cerevisiae  Mcm2p  and  the  fission  yeast  ndal ÷  gene 
product (Todorov et al., 1994). Microinjection of an anti- 
body raised against recombinant BM28 into synchronized 
mouse NIH3T3  or human IMR-90  and HeLa cells pre- 
sents evidence for the involvement of the protein in DNA 
replication.  When  injected  during  G1  phase,  the  anti- 
BM28 antibody inhibits the onset of subsequent DNA syn- 
thesis as tested by the incorporation of bromodeoxyuri- 
dine (BrdU). However, in contrast to the results obtained 
for  Mcm2p,  our  initial  immunocytochemical  data  for 
BM28  had  shown  a  nuclear  localization of the  protein 
throughout interphase. 
In this report, we show that although always localized in 
the  nucleus,  prefixation treatment with nonionic deter- 
gents reveals that BM28 has different extractability during 
the cell cycle, being tightly bound to a nuclear component 
only during the G1 and early S phases of the cell cycle. In 
addition, this binding seems to be related to chromatin in- 
tegrity,  as  DNase  I  digestion  releases  the  majority  of 
bound BM28 from G1 and early S phase nuclei. We also 
document posttranslational modification changes  in  the 
BM28  protein, which may be  relevant to  this behavior. 
Our results suggest that BM28 is chromatin bound during 
G1, but is displaced during DNA replication and cannot 
rebind until an event in late mitosis. As such, BM28 could 
be involved in the control that allows the replication ap- 
paratus to distinguish replicated from unreplicated chro- 
matin. 
Materials and Methods 
Cell Culture 
HeLa, mouse NIH3T3 cells (Todorov et al., 1994), and buffalo rat BRL3A 
cells (Dulak and Temin, 1973)  were grown in DME supplemented with 
10% FCS and 1% antibiotic/antimycotic solution (GIBCO BRL, Paisley, 
UK). HeLa cells were  synchronized in mitosis using mitotic shake-off, 
following  or  not  following  nocodazole  treatment  as  described  earlier 
(Todorov et al., 1994; see also Johnson et al., 1993).  For a mitotic arrest, 
40 ng/ml of nocodazole was added for 10-12 h. These cells were used also 
as a G1 source 4-6 h after replating. For another G1 source, cells were ar- 
rested in early G1 by 20 p,M lovastatin (generous gift of Dr. A. Alberts, 
Merck Research Laboratories, Rahway, NJ) for 24 h, followed by a  re- 
lease in 1 mM mevalonic acid (Sigma Chemical Co, St. Louis, MO) for at 
least 2 h (Keomarsi et al., 1991; Jakobisiak et al., 1991).  In our hands, the 
cells remained in G1 phase up to 7-8 h  after the mevalonic acid release 
and then entered synchronously  into S phase, giving >90% of BrdU-posi- 
tive cells (see below) 10 h after the release. This time point was used as a 
source of early S cells in some experiments. Cells were also arrested in 
early S phase with 2  mM hydroxyurea for 16 h  and released by several 
washes in fresh medium (Todorov et al., 1994).  After this block, the cells 
remained in S phase up to 7-8 h after the release as judged by BrdU incor- 
poration. Cells were considered to be in early S phase 2 h after the release 
from hydroxyurea and in late S phase 6 h after the release. For most of the 
cell cycle points more than one method of synchronization was used, to 
avoid artifacts due to the action of the drugs. In all experiments, the effi- 
ciency of cell synchronization was assessed by BrdU labeling followed by 
immunostaining with anti-BrdU antibody. The cells were pulsed for 15 
min with 20 IxM BrdU, and 1 ~M fluorouridine (Bravo and McDonald- 
Bravo, 1987) before extraction and fixation. 
Cell Extractions 
The extractions were performed directly on cells grown on coverslips (in 
situ extractions) or on cells in suspension. The ceils were washed with PBS 
and with cytoskeleton (CSK) buffer (10 mM Pipes, pH 7.0, 100 mM NaC1, 
300 mM sucrose, 3 mM MgCI2)  (Fey et al., 1986).  Then the cells were ex- 
tracted with CSK buffer containing 0.5% Triton X-100, 0.5 mM PMSF, 10 
~g/ml of each of leupeptin and aprotinin (Boehringer Mannheim, GmbH, 
Mannheim, Germany) for 5 rain at 20°C. In the case of nuclease diges- 
tions, 100 ~g/rnl DNase I  and/or RNase A  (Sigma Chemical Co.) were 
added to the extraction buffer. After a wash in CSK buffer, the coverslips 
were fixed in 4% paraformaldehyde in CSK buffer for 30 min on ice and 
processed for immunofiuorescence. 
For biochemical analysis the cells were  scraped in PBS containing 2 
mM MgCI2 and 0.5 mM PMSF, washed with PBS and CSK buffer, and ex- 
tracted as described above. The cells were digested for 5 rain at 20°C in 5 
vol CSK buffer containing Triton X-100, protease inhibitors, and/or nu- 
cleases. The remnants and extracts were separated by centrifugation at 
700 g for 5 rain. The pellets were washed once with CSK buffer, and the 
supernatants  were  added  to  the  corresponding  extract  fractions.  All 
samples were  finally lysed in electrophoresis sample buffer for further 
analysis. 
Immunofluorescence Microscopy 
For immunolocalization, all the steps, except the final washes, were per- 
formed in a  blocking solution (1%  BSA, 100 mM lysine in PBS). Para- 
formaldehyde-fixed cells were first blocked for 30 rain and then incubated 
for  2  h  at  20°C  with  20  i~g/ml  affinity-purified  anti-BM28  antibody 
(Todorov et al., 1994). In most of the experiments, both antibodies against 
the NH2 and COOH-terminal regions of BM28 were used and displayed 
the same staining pattern.  A  FITC- or Texas red--conjugated goat anti- 
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alize  the  staining.  In  some  experiments, double  staining with  mouse 
monoclonal anti-proliferating cell nuclear antigen (PCNA), anti-BrdU an- 
tibodies (Boehringer Mannheim GmbH) or antibodies against the 34- and 
70-kD subunits of the replication protein A (Kenny et ai., 1990; kindly do- 
nated by Dr. J. Hurwitz, Memorial Sloan-Kettering Cancer Center, New 
York) was performed. These antibodies were visualized using FITC- or 
Texas red-c,  onjugated horse anti-mouse IgG (Vector Laboratories, Inc.). 
During the final washing steps, 0.2 ttg/ml DAPI (4,6-Diamino-2-phenylln- 
dole) (Sigma Chemical Co.) was added for DNA staining. The slides were 
mounted in Vectashield (Vector Laboratories, Inc.) and visualized on a 
fluorescence photomicroscope (Axioskop; Zeiss, Oberkochen, Germany). 
The pictures were taken on a T-Max 400 film (Eastman Kodak Co., Roch- 
ester, NY). 
Phosphorylation Analysis 
To study the phosphorylation of the BM28 protein, HeLa cells were la- 
beled with [32p]orthophosphate (ICN Biomedicals, Inc., Costa Mesa, CA) 
in 35-mm petri dishes as follows. Cells synchronized in different phases of 
the cell cycle as described above were washed with phosphate-free  medium 
based on DME (GIBCO) and preincubated for 30 min at 37°C with phos- 
phate-free medium containing 5% dialyzed FCS. [32p]Orthophosphate was 
added to reach I mCi/ml, and cells were incubated for 2 h at 37°C. The cells 
were rinsed with cold PBS in the petri dishes and solubillzed in lysis buffer 
containing 20 mM Na phosphate as described above. The lysate was immu- 
noprecipitated with an anti-BM28 antibody. The immunoprecipitate was 
eluted, resolved on SDS gels, and immunoblotted. The 32p labeling was de- 
tected by autoradiography. 
Image Analysis 
For quantitation of BM28 and DNA fluorescence intensities, the micros- 
copy was done on an inverted microscope (model IM35; Zeiss) equipped 
with a CC200 cooled charged-coupled device camera (Photometrics, Ltd., 
Tucson, AZ). Random fields of view were selected, and images were col- 
lected at 12 bits under subsaturating illumination conditions, corrected to 
account for nonuniform illumination over the observed field, and archived 
for later analysis. Subsequent analysis of these images was performed on a 
Macintosh LCII computer using the public domain NIH-Image v.1.55 pro- 
gram written by Wayne Rasband  at  the National  Institutes of Health 
(available from NTIS, 5285 Port Royal Rd., Springfield, VA 22161, part 
number  PB93-504868).  In brief, the  DAPI  images were  automatically 
thresholded to isolate nuclei from their background. The background was 
then masked out in both FITC and DAPI images, and pixel intensities of 
the nuclei were measured, averaged, and integrated over the pixel area of 
each nucleus. Those nuclei touching the edge of the visual field, or those 
not rendered distinct from neighboring nuclei by the thresholding, were 
excluded from analysis. 
Quantitative analysis of autoradiographs and gels was performed on a 
densiton meter (BioImage; Millipore Corp., Bedford, MA) using whole 
band analyzer software. 
Protein Electrophoresis and Immunoblotting 
For protein analysis, the samples were lysed by boiling in electrophoresis 
sample buffer and separated on 7.5% SDS-polyacrylamide gels according 
to Laemmli (1970),  using long migration times to resolve the different 
forms of BM28. The gels were electroblotted on nitrocellulose membranes 
(Schleicher & Schuell, Dassel, Germany) using a semidry electroblotting 
system, and the blots were blocked in 2%  nonfat dry milk in PBS and 
probed with 1 p,g/ml anti-BM28 antibody, followed by an alkaline phos- 
phatase-conjugated goat anti-rabbit IgG (Vector Laboratories, Inc.). 
Imraunoprecipitation 
For immunoprecipitation, the cells were rinsed with PBS and solubilized 
in the petri dishes with lysis buffer (150 mM NaC1, 50 mM Tris, pH 7.8, 1 
mM EGTA,  1% Triton X-100, 0.5%  sodium deoxycholate, 0.05%  SDS, 
0.5 mM PMSF, and 20 p,g/mi of both leupeptin and aprotinin) for 15 min 
on ice. The lysates were cleared for 15 min at 13,000 g and immunoprecip- 
itated with 20 p,g/ml anti-BM28 antibody for 60 rain at 4°C, followed by 
the addition of 10 ixg/ml goat anti-rabbit IgG for another 30 min. Finally, 
50 I~1 protein G-Sepharose 4 Fast Flow (Pharmacia Inc., Piscataway, NJ) 
were added to each sample for 1 h  at 4°C. The slurry was washed three 
times with lysis buffer, three times with lysis buffer containing 0.6 M NaCI, 
and finally with PBS. The proteins were extracted by boiling in electro- 
phoresis sample buffer, resolved in SDS-PAGE gels, and immunoblotted 
as described above. 
For dephosphorylation (Carmo-Fonseca et al., 1993; Wang et al., 1994) 
the Sepharose slurries from immunoprecipitation were digested for 30 
min at 30°C with 200 U  h-phosphatase (New England Biolabs, Beverly, 
MA) according to the suggestions of the supplier in phosphatase buffer 
(50 mM Tris-HCl, pH 7.8, 2 mM MnCl2; 5 mM DqT, 0.1 mg/ml acetylated 
BSA) containing protease inhibitors as above. Control samples were incu- 
bated in the same conditions in buffer without phosphatase. After the in- 
cubation, the samples were washed with PBS, eluted with SDS-PAGE 
sample buffer, and resolved on polyacrylamide gels, followed by immuno- 
blotting. 
Results 
Cell Cycle-dependent Changes in the Nuclear 
Retention of BM28 
Our previous immunolocalization and immunoblotting data 
suggested that neither the level nor localization of the hu- 
man BM28 protein varies dramatically during the cell cycle. 
In cell fractionation experiments, however, we noticed that 
a  proportion of BM28 is readily lost from permeabilized 
cells, suggesting that the protein may not be tightly bound 
to nuclear components (see below). Given that the related 
Mcm2p in S. cerevisiae  is located in the nucleus only during 
the interval from mitosis to early S phase, we investigated 
whether there might not be more subtle changes in BM28 
distribution during the cell cycle. Instead of fixing cells in 
the normal way for indirect immunofluorescence, we first 
permeabilized the cells  with a nonionic detergent directly 
on coverslips just before fixation (termed here "in situ ex- 
traction"). This procedure is based on the methods used to 
extract soluble cellular proteins as an initial step of in situ 
preparations of nuclear matrix or other nuclear structures 
(Staufenbiel and Depper, 1984; Fey et al., 1986; Nakayasu 
and Berezney, 1989; Gerdes et al., 1994). With this method, 
the result was strikingly different; cells showed considerable 
variation in nuclear staining with the anti-BM28 antibody, 
implying that the antigen could be efficiently  extracted from 
a subset of cells (Fig. 1). Some cells showed an intensity of 
nuclear fluorescence similar to  that found with normally 
fixed cells (Fig.  1 C, arrowheads), whereas others showed 
hardly any staining with the anti-BM28 antibody (Fig. 1 C, 
small arrows). In the initial experiments, we used three cell 
lines of different origin: buffalo rat BRL3A (Fig. 1), human 
HeLa cells (Figs. 2, 3, 8, and 10), and mouse NIH3T3 (not 
shown); all gave similar results. For extraction, we usually 
used 0.5% Triton X-100, but identical results were obtained 
with other nonionic detergents, such as NP-40. 
Given the yeast results with Mcm2p, an obvious expla- 
nation for this variation is that BM28 is more sensitive to 
detergent extraction in certain phases of the cell cycle. To 
test this prediction, unsynchronized HeLa cells were dou- 
ble stained for BM28 and DNA, and the images (Fig. 2, A 
and  B)  were  collected  using  a  charged-coupled  device 
camera to allow quantitation of the fluorescence images 
(see  Materials  and Methods).  Analysis of several  fields 
showed an inverse correlation between the average FITC 
fluorescence intensity (proportional to BM28 concentra- 
tion) and the integrated DAPI fluorescence intensity (pro- 
portional to DNA content) of individual nuclei (Fig. 2 C). 
Todorov et al. Displacement of  Human Mcm2p during S Phase  1435 Figure 1.  Immunolocalization of BM28 in the nuclei of nonextracted and extracted cells. Triton X-100 extraction reveals marked differ- 
ences in the nuclear BM28 content among cells, from barely detectable (small  arrows), partially extracted (large arrows), to practically 
unaffected (arrowheads). Nonsynchronized  BRL3A cells were fixed with paraformaldehyde (A and B) or fixed after extraction with 
0.5% Triton X-100 (C and D). The cells were double stained with an anti-BM28 antibody, followed by a FITC-conjugated second anti- 
body (A and C) and for DNA with DAPI (B and D) and visualized on a fluorescence photomicroscope. Bar, 10 txm. 
This suggested that BM28 is more readily extracted from 
cells that have replicated their DNA. In a second experi- 
ment, we synchronized HeLa cells in G1 with lovastatin or 
in early S phase with hydroxyurea and examined the ex- 
tractability of BM28 at different time points after release 
from the inhibitors. In cells synchronized in G1 (2-6 h af- 
ter release from a  lovastatin  block; Fig.  3  B)  or early S 
phase cells (not later than 2 h after release from a hydroxy- 
urea block, Fig. 3 C; or 10 h after release from a lovastatin 
block, not shown)  the BM28 antigen is nuclear,  showing 
an intensity and pattern of staining comparable to that of 
nonextracted  cells.  In  such  cells,  the  pattern  of  BM28 
staining is almost indistinguishable  from the  distribution 
of DNA revealed by DAPI (Fig. 2, A  and B; see Fig. 8, A 
and  B).  Cells  released  for  >4  h  from  the  hydroxyurea 
block show a less uniform distribution of BM28 (Fig. 3 D), 
and 6 h after the release, relatively little BM28 can be de- 
tected in the nucleus (Fig. 3 E). At this stage, the remain- 
ing antigen is concentrated in "speckles" and in the peri- 
nucleolar  region.  Cells  released  from  the  hydroxyurea 
block for 8-10 h, which are in G2, often show faint BM28 
staining in the nuclear envelope region (Fig. 3 F). Thus, as 
S phase proceeds, there is a considerable reduction in the 
nuclear retention of BM28, although a small proportion of 
BM28  may  be  refractory  to  extraction  even  in  the  G2 
phase.  This  may  represent  a  nuclear  compartment  to 
which a  minor amount of BM28 is bound throughout in- 
terphase.  Overall, these  results  are  reminiscent  of those 
obtained  with  Mcm2p  in  S.  cerevisiae, in  that  during  S 
phase  there  appears to be  a  reduction  in  the  affinity of 
BM28 for some nuclear structure.  Unlike the situation in 
yeast cells, however, the human protein remains in the nu- 
cleus during G2. 
Analysis of BM28 in Cell Extracts 
To  determine  whether  the  changes  detected  by indirect 
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Figure 2.  The intensity  of BM28 staining in extracted cells is in- 
versely proportional to a parallel staining  for DNA. HeLa cells 
were extracted with Triton X-100, fixed, and stained  as shown in 
Fig. 1. The images for BM28 (A) and DNA (B) staining  were 
taken with a CCD camera and analyzed as described in Materials 
and Methods.  In C, the data points on the graph represent indi- 
vidual  nuclei  and relate the mean FITC fluorescence  intensity 
(proportional to BM28 concentration) to the integrated DAPI in- 
tensity  (proportional  to  DNA  content)  for  a  specific  nucleus 
shown  in A  and B. The axes are calibrated in  arbitrary units, 
immunofluorescence microscopy reflected some biochemi- 
cal change in BM28, we examined the protein in whole cell 
extracts by immunoblotting  (Fig.  4).  We  had  previously 
shown that two affinity-purified antibodies against BM28 
(against NH2- and COOH-terminal fragments) recognized 
a single polypeptide in immunoprecipitation and immuno- 
blotting experiments (Todorov et al., 1994).  However, by 
running  low-percentage  acrylamide  gels,  we  found  that 
while both antibodies detect a  single band of ~125 kD in 
whole-cell extracts prepared from mitotic cells, two closely 
migrating  bands  could  be  detected  in  extracts  prepared 
from interphase cells. Similar results were obtained using 
"shaking  off"  mitotic  enrichment  of  either  nocodazole- 
arrested or nonsynchronized HeLa cells. Preparing whole- 
cell extracts from populations enriched in G1, S, and G2 
phases, we found that the proportion of these two forms of 
BM28 varies during the cell cycle. Thus in mitotic cells, the 
form with higher mobility is predominant (designated sub- 
sequently as the "fast" form), while in G1 extracts most of 
the BM28 appears to be in the form with lower mobility 
(designated  subsequently  as  the  "slow"  form).  As  cells 
progress  through  interphase,  the  proportion  of the  fast 
form increases,  and  at  the  same  time,  there  is  a  corre- 
sponding  reduction  in  the  relative  amount  of  the  slow 
form, suggesting that there is an interconversion between 
the two forms. On some gels, intermediate bands between 
the fast and slow forms can be resolved in extracts made 
from  interphase  cells  (not  shown).  The  overall  protein 
concentration of BM28 in cells in different cell cycle stages 
appears to be similar, which is not unexpected given that 
the  levels  of mRNA  are  constant  during  the  cell  cycle 
(Todorov et al., 1991). 
The dynamics of the change in the fast and slow bands 
detected  by  the  anti-BM28  antibody  suggests  that  the 
BM28 protein is in some way altered during the cell cycle. 
In particular, the very rapid shift from the fast to the slow 
form  during  the  M/G1  transition  is  more  suggestive  of 
posttranslational  modification than  partial  proteolysis or 
de novo protein synthesis. 
BM28 is a Phosphoprotein 
We investigated the possible role of phosphorylation as a 
posttranslational modification of the BM28 protein. HeLa 
cells were synchronized in various stages of the cell cycle 
and grown in the presence of [32p]orthophosphate. BM28 
was  isolated  by  immunoprecipitation  and  analyzed  by 
SDS-PAGE  and  Western  blotting  (Fig.  5).  This analysis 
clearly shows  that  BM28  is  a  phosphoprotein,  and  both 
fast  and  slow  forms of the  protein  are  phosphorylated. 
During the whole length of interphase, the fast form of the 
protein appears to be approximately fourfold more phos- 
phorylated than the slow form. 
and a simple linear regression  line is shown fitted by the method 
of least squares (r = -0.9).  The analysis shows that nuclei with a 
high DNA content (presumably G2 nuclei) have a lower BM28 
concentration than nuclei with a lower DNA content (G1 nuclei). 
Analysis of six other randomly selected  fields gave a similar re- 
sult (not shown). Bar in B, 10 ixrn. 
Todorov  et al. Displacement of  Human Mcm2p during S Phase  1437 Figure 3.  The extractability of BM28 increases through the cell cycle. HeLa cells were synchronized in G1 2 h after a release from a lov- 
astatin block (B), and in S phase with hydroxyurea. The cells were considered to be in early S phase 2 h after release from a hydroxyurea 
block (C), in mid-S phase 4 h after release (D), and in late S phase 6 h after release (E). The cells were considered to be in G2 phase 10 h 
after release from a hydroxyurea block (F). All stages were assessed by parallel BrdU staining (see Materials and Methods). The cells 
were fixed and stained for BM28 as in Fig. 1. The protein is tightly bound in the nuclei during G1 (B) and early S (C) phases, more ex- 
tractable during mid-S (D) and easily extractable in late S (E) and G2 (F) phases. Neither of the inhibitors affects the pattern of BM28 
staining compared with nonsynchronized  cells (A). Bar, 10 Ixm. 
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BM28  during  the  cell  cycle. 
HeLa  cells  were  synchronized 
in  mitosis  with  nocodazole 
(lane 1), in G1 2 h after release 
from a lovastatin block (lane 2), 
in early S phase 2 h after release 
from  a  hydroxyurea  block 
(lane 3), and in G2 10 h after re- 
lease  from  hydroxyurea  (lane 
4). The cells were lysed in SDS 
electrophoresis  sample  buffer, 
separated in a 7.5%  SDS-poly- 
acrylamide  gel,  and  blotted 
onto nitrocellulose.  BM28  was 
identified using a reaction with 
its  specific  antibody and an al- 
kaline  phosphatase-conjugated 
second antibody. The migration of Biorad protein standards is in- 
dicated. Approximate proportions of BM28 protein in the two 
electrophoretic  forms  are  as  follows  (fast:slow):  G1  (<20%: 
>80%); early S (30%:70%); G2 (40%:60%); M (>80%:<20%). 
We also investigated whether the mobility changes shown 
by BM28 could be directly ascribed to changes in phospho- 
rylation. Digestion of immunoprecipitates  of BM28 with h 
phosphatase decreased the relative mobility of the fast form 
to a position close to the slow form (Fig. 6). Such a shift was 
detected  in all phases  of the cell cycle. Thus, the  dephos- 
phorylated  form of BM28  has  a  lower mobility  on SDS- 
polyacrylamide  gels  than  the  hyperphosphorylated  form. 
Although this is opposite to the relationship usually found 
for  phosphorylated  proteins,  it  might  be  related  to  the 
abnormal  mobility  of BM28  in  SDS-polyacrylamide  gels 
(Todorov et al., 1994). 
Figure 6.  k-Phosphatase digestion alters the electrophoretic mo- 
bility  of BM28,  shifting  the fast form to a  slower mobility. Ex- 
tracts from unsynchronized HeLa cells  (lanes  7 and 8) or from 
cells synchronized in mitosis (lanes 1 and 2), G1 (lane 3 and 4), 
and S (lanes 5 and 6) phases as in Fig. 4 were immunoprecipitated 
with an anti-BM28 antibody as described in Materials and Meth- 
ods. Half of each immunoprecipitate was digested with h-phos- 
phatase (lanes 2, 4, 6, and 8), while the rest was kept as a control 
(lanes 1, 3, 5, and 7). The immunoprecipitates were eluted and re- 
solved as in Fig. 4. 
Cell Fractionation of BM28 
To corroborate the results obtained by the in situ extrac- 
tion  method,  we  examined  the  distribution  of BM28  on 
Western  blots  after  crude  cell  fractionation.  HeLa  cells 
Figure 5.  BM28 is a phosphopro- 
tein.  HeLa  cells  were  synchro- 
nized in mitosis,  G1, and S phases 
with nocodazole, lovastatin, or hy- 
droxyurea blocks and labeled with 
[32p]orthophosphate for 2 h as de- 
scribed in Materials and Methods. 
Mitotic cells (lane 1) were labeled 
adding the isotope to nocodazole- 
arrested  ceils.  G1  (lane  2)  and 
early S (lane 3) phase cells  were 
labeled after release from lovasta- 
tin or hydroxyurea blocks. For la- 
beling late S/G2 phase ceils  (lane 
4),  the  [32p]orthophosphate  was 
added 6 h  after release  from the 
hydroxyurea block. All cells were 
lysed and immunoprecipitated with 
the  anti-BM28 antibody. The im- 
munoprecipitate  was  resolved  as 
in Fig. 4 and blotted onto nitrocel- 
lulose.  BM28 was identified by an 
immune  reaction  (B),  and  the 
membranes were exposed for au- 
toradiography (A). 
Figure 7.  Differential extractability of BM28 during the cell cy- 
cle.  HeLa cells  were  synchronized in  G1  (lanes  1-3), early S 
(lanes 4--6), G2 (lanes 7-9), and mitosis (lanes 10-12) as in Fig. 4. 
An aliquot of the cells was lysed directly in electrophoresis buffer 
to give total (T) cellular proteins (lanes 1, 4, 7, and 10). The rest 
was extracted with 0.5% Triton X-100, and the pellet (P; lanes 2, 
5, 8, and 11) and the extract (E; lanes 3, 6, 9, and 12) were solubi- 
lized in a  sample buffer and loaded by a  manner to represent 
equal amounts of cells. The samples were separated and immuno- 
blotted  as in Fig.  4.  The proportion of BM28  that  can be  ex- 
tracted at different cell  cycle stages is  as follows:  G1, 25%; S, 
35%; G2, 75%; M, 95%. 
Todorov  et al. Displacement  of  Human Mcm2p  during S Phase  1439 Figure 8.  The non-detergent extractable form of BM28 is sensitive to DNase I digestion. HeLa cells were synchronized  in G1 2 h after 
release from a lovastatin  block. The cells were extracted with 0.5% Triton X-100 alone (A and B) and in the presence of RNase A (C 
and D) or DNase I (E and F). The cells were fixed and stained for BM28 (A, C, and E) and DNA (B, D, and F) as in Fig. 1. Practically 
the same pattern of staining was detected also after digestion of early S phase cells (10 h after release from a lovastatin block or 2 h after 
release from a hydroxyurea block). Bar, 10 t~m. 
were synchronized by mitotic shake-off, lovastatin, or hy- 
droxyurea, and cells were extracted with Triton X-100 un- 
der conditions similar to those used in the in situ extrac- 
tion experiments. Extracted cells were then separated into 
pellet (P) and supernatant (E) fractions by centrifugation 
(Fig.  7).  Microscopic examination of the  pellet fractions 
showed  that  they  retained  good  nuclear  morphology. 
Comparing the immunoblots of the pellet and supernatant 
fractions, we found that most BM28 remained in the pellet 
when G1 cells are extracted, while in G2 the majority of 
the  protein  is  soluble  (Fig.  7  legend).  In  mitotic  cells, 
hardly any BM28 is detectable in the pellet fraction. Thus, 
in  agreement with the  in  situ  extraction results,  we  find 
that most BM28 cannot be solubilized by detergent in G1, 
but a change occurs during S phase to allow the protein to 
be more readily extracted from detergent-permeabilized 
cells. In this analysis, we also detected both fast and slow 
forms of BM28 during interphase.  When both forms are 
present (for instance, in S and G2 cells), the slow form is 
clearly enriched in the pellet, suggesting that this form is 
more  tightly bound  than  the  fast form (Fig.  7,  compare 
lanes 4 and 5, 7 and 8). 
The Journal of Cell Biology, Volume 129, 1995  1440 Figure 9.  DNase I digestion releases BM28 from G1 and early S 
phase ceils. HeLa cells were synchronized in G1 (A) by lovastatin 
and in early S phase (B) by hydroxyurea as above. An aliquot of 
the cells was lysed to give total cellular proteins (lane 1). The rest 
was separated into equal parts and extracted as in Fig. 8 with Tri- 
ton X-100 alone (lanes 2 and 3) and in the presence of DNase I 
(lanes 4 and 5), RNase A (lanes 6 and 7), and DNase I + RNase 
A  (lanes 8 and 9). The loading, separation,  and analysis of the 
pellets (lanes 2, 4, 6, and 8) and extracts (lanes 3, 5, 7, and 9) were 
essentially as in Fig. 7. The approximate proportion of BM28 that 
can be extracted after the different treatments is as follows: G1, 
control: 25%; G1, DNase: 80%; G1, RNase: 20%; G1, DNase and 
RNase: 80%; S, control: 40%; S, DNase: 80%; S, RNase: 50%; S, 
DNase and RNase: 75%. 
Chromatin Association of BM28 
As mentioned above, the general pattern of BM28 immu- 
nofluorescence in G1 and early S phase cells is very similar 
to the staining for DNA with DAPI. This similarity is en- 
hanced in Triton X-100-extracted cells (Fig. 2, A  and B; 
Fig.  8, A  and  B),  suggesting  that  bound  BM28  may be 
chromatin associated. To examine the nature of the subnu- 
clear structure associated with BM28,  we carried out in 
situ extractions in the presence of RNase A  or DNase I. 
RNase A had almost no effect on the distribution of BM28 
(Fig.  8  C),  suggesting that RNA-containing structures in 
the nucleus are not important for retention. In contrast, 
DNase I treatment resulted in the loss of BM28 staining, 
leaving only faint "speckled" structures surrounding the 
nucleoli  (Fig.  8  E).  In  immunoblotting  experiments  we 
found similar  results  (Fig.  9).  The  association  of BM28 
with the pellet of detergent-extracted G1 and early S cells 
was not affected by RNase A  digestion, but there was a 
clear solubilization of BM28 on DNase  I  treatment.  On 
detergent treatment alone, ~25%  of BM28 was released 
from G1 cells, which is similar to the percentage of total 
cell proteins released under these conditions. With DNase 
I, >80%  of BM28 was released, while the percentage of 
total proteins extracted was similar to that obtained with 
detergent treatment alone, and the core histones were not 
released (data not shown; Fey et al., 1986). These experi- 
ments suggest that the bound form of BM28 is largely as- 
sociated  with  chromatin.  Similar  results  have  been  re- 
ported for Mcm2p, where the binding of this protein to G1 
nuclei was also shown to be abolished by DNase I  diges- 
tion (Yan et al., 1993). 
We also investigated the nature of the nuclear domain 
that is labeled by anti-BM28 antibodies after detergent ex- 
traction of mid- to late S phase cells (Fig. 3). PCNA, the 
auxiliary subunit of DNA polymerase 8, shows a  charac- 
teristic nonuniform distribution in S phase nuclei that re- 
flects discrete sites of DNA replication (Bravo and Mac- 
donald-Bravo, 1987). However, simultaneous staining with 
BM28 and PCNA indicates that the speckled distribution 
of BM28 in extracted mid-S phase nuclei does not coin- 
cide with the pattern of PCNA staining (Fig. 10, A and B). 
Similarly, simultaneous labeling with BrdU, to label repli- 
cation loci, and staining for BM28 reveals patterns that are 
dissimilar (Fig. 10, C and D). The patterns of staining ob- 
tained are widespread, and some overlap in the distribu- 
tion of PCNA  or newly incorporated BrdU  with BM28 
probably occurs in mid-S phase cells, but the gross distri- 
butions seem quite different. We also compared the distri- 
bution of BM28 with replication protein A  (RPA), which 
is  a  single-stranded  DNA-binding  protein  required  for 
DNA  replication,  repair,  and  possibly  recombination 
(Kenny et al.,  1990;  Longhese et al.,  1994). In extracted 
cells, mAbs to the 34- (Fig. 10 F) and 70-kD (results not 
shown) subunits of RPA show widespread granular stain- 
ing of the nucleoplasm, similar to results obtained using 
nonextracted cells  (data  not  shown;  Kenny et  al.,  1990; 
Adachi and Laemmli, 1992;  Cardoso et al.,  1993). In ex- 
tracted  G1  nuclei, the pattern  of BM28  staining  clearly 
overlaps  that  of RPA,  since  both  antibodies  effectively 
"paint" the nucleus. Cells in later stages of the cell cycle 
were progressively extracted for BM28,  but  staining  for 
the RPA subunits did not diminish in intensity, and zones 
that stained for residual BM28 do not appear to be en- 
hanced for RPA staining. Thus BM28 does not appear to 
concentrate in sites of active replication and behaves quite 
differently from RPA in terms of susceptibility to deter- 
gent extraction. 
Comparing the level of BM28 in cell extracts with bacu- 
lovirally expressed BM28 of known concentration, we esti- 
mate  that  there  are  ~'-,105 molecules  of protein per  cell 
(data  not  shown).  Thus,  BM28  is  an  abundant  protein, 
present at a  level similar to that reported for other pro- 
teins thought to take part in chromatin structure, such as 
topoisomerase II (Gasser et al., 1986), matrix/scaffold at- 
Todorov et al. Displacement of  Human Mcm2p during S Phase  1441 Figure 10.  Lack of general colocalization of BM28 and DNA replication sites or PCNA. Detergent-extracted HeLa cells were double 
stained with anti-BM28 and a Texas red-conjugated second antibody (A, C, and E), anti-PCNA (B), anti-BrdU (D), or antibody against 
the 34 kD subunit of RPA (F) and FITC-conjugated second antibodies. Bars, 10 ~m. 
tachment region-binding protein (von Kreis et al., 1991), 
and NuMa (Compton et al., 1992; Yang et al., 1992). 
Discussion 
Our initial immunofluorescence studies indicated that the 
BM28 protein is nuclear throughout interphase, suggesting 
that the changes in nuclear localization shown by Mcm2p 
and related proteins in S. cerevisiae  (Hennessy et al., 1990; 
Yan et al., 1993) do not represent a conserved phenome- 
non in eukaryotic cells. However, by perrneabilizing cells 
with nonionic detergents, we find that BM28 shows a cell 
cycle dependence in its nuclear binding. From late mitosis 
until S phase, nuclei contain BM28 that is refractory to de- 
tergent extraction, but as S phase proceeds, BM28 binding 
is  lost.  Since BM28  remains  bound  to  S  phase  nuclei if 
DNA replication is inhibited by hydroxyurea treatment, 
DNA synthesis per se may be required to displace the pro- 
tein.  The  nonextractable  form  of BM28  appears  to  be 
bound to chromatin. In extracted G1 nuclei, the BM28 dis- 
tribution  is  very similar  to  that  of DNA,  as judged  by 
DAPI staining, and BM28 can be released by DNase I di- 
gestion. During S phase, the distribution of BM28 changes 
dramatically,  no  longer  showing  an  obvious  correlation 
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BM28 binding is seen in perinucleolar and envelope re- 
gions.  During  S  phase,  we  had  previously  shown  that 
BM28 does not concentrate in replication loci (Todorov et 
al., 1994), visualized by BrdU incorporation (Nakamura et 
al., 1986; Fox et al., 1991). In extracted mid-S phase cells, 
where BM28 antigen shows a speckled distribution, a simi- 
lar result is  obtained, and we  also fail to detect general 
colocalization with PCNA, which is an accessory subunit 
of DNA  polymerase  ~  (Bravo  et  al.,  1987),  and  RPA. 
Thus, BM28 is not enriched in the subnuclear loci, which 
represent the sites of active DNA synthesis (Cook, 1991). 
In addition to changes in extractability, we have discov- 
ered cell cycle changes in the electrophoretic mobility of 
BM28 that may be related to the variation in the ease with 
which the protein can be removed from nuclei. The transi- 
tion from mitosis to G1 is accompanied by a very rapid al- 
teration in BM28 from a fast- to a slow-migrating form, and 
simultaneously, most BM28 becomes nonextractable with 
detergent. From S phase, there is a steady conversion of the 
protein from the  slow- to  the  fast-migrating form. Thus, 
there  is  a  close  correlation between mobility changes  in 
BM28, which we take to indicate some form of posttransla- 
tional modification, and changes in its nuclear affinity. Al- 
though these observations do not establish a causal link, the 
obvious possibility that a putative posttranslation modifica- 
tion is responsible for changes in binding are supported by 
cell fractionation experiments, which indicate that the slow 
form of BM28 is less detergent extractable than the  fast 
form. The difference between the fast and slow forms of 
BM28 appears to be due to the level of phosphorylation; the 
higher level of phosphorylation of the fast form could affect 
its ability to bind chromatin. We note that the behavior of 
BM28 during the cell cycle, in terms of its varying extract- 
ability and the appearance of distinct forms in mitosis and 
G1, could allow its use as a marker for cell cycle transitions 
using  assays based  on immunofluorescence and  immuno- 
blotting. 
These  results  are  interpreted  in  terms  of  the  model 
shown in Fig. 11. At a stage in late mitosis, BM28 is rapidly 
converted from a  fast to a  slow form by partial dephos- 
phorylation and at the same time binds to decondensing 
chromatin. During S phase,  displacement of BM28 from 
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Figure 11.  Model of BM28 localization and modification changes 
during the cell cycle. Solid circles represent the slow form and 
open ovals the fast form of BM28. Chromatin bound BM28 is dis- 
placed by DNA replication  and cannot rebind until the start of 
the next G1 phase, potentially  providing a "flag" to distinguish 
replicated from unreplicated chromatin. 
chromatin occurs perhaps as a result of activation of repli- 
cation origins or elongation of replication forks. Displaced 
BM28 can diffuse out if the nuclear membrane is perme- 
abilized by detergent, but in living cells the protein does 
not accumulate in the cytoplasm. This displacement from 
chromatin may require, or allow, conversion of BM28 to 
the fast form by hyperphosphorylation. Displaced protein 
may be incapable of rebinding to chromatin in oS phase, 
perhaps due to inappropriate posttranslational modifica- 
tions, or binding may be dependent on other factors avail- 
able only during an "assembly" window during late mito- 
sis. Finally, during mitosis, all BM28 is converted into the 
soluble  fast  form  and  remains  extrachromosomal  until 
telophase. 
The recent finding  that  there appears  to be  a  default 
pathway of export for nuclear proteins that are not bound 
to  some  nuclear  structure  (Schmidt-Zachmann  et  al., 
1993) requires some comment. We suggest that BM28 may 
not be subjected to default export pathway either because 
it is too large (perhaps complexed with other proteins) or 
export does occur, but constitutive rapid import prevents 
cytoplasmic accumulation. 
Overall, the behavior of BM28 is thus not so different to 
that  shown by Mcm2p and related proteins in  yeast, al- 
though the Mcm proteins disappear from the nucleus after 
DNA replication, either as a result of export or degrada- 
tion (Hennessy et al., 1990; Yan et al., 1993). Also, unlike 
BM28, the yeast proteins can be detected in the cytoplasm 
during  interphase.  This  may  well  indicate  that  nuclear 
transport of the Mcm proteins is  restricted to a  discrete 
phase of the cell cycle, as has been shown for Swi5p (Moll 
et  al.,  1991),  but  alternatively,  the  proteins  could  con- 
stantly shuttle between cytoplasm and nucleus and only be 
retained  during  the  interval from mitosis  to  S  phase.  If 
both BM28 and the Mcm proteins shuttle between cyto- 
plasm and nucleus throughout the cell cycle, then the rea- 
son why human but not yeast nuclei retain the protein af- 
ter DNA replication could simply reflect differences in the 
relative rates of nuclear import and export. 
The cell cycle change in nuclear association of BM28 is 
broadly similar  to  that  of routine  P1,  very recently re- 
ported by Kimura et al. (1994). BM28 and P1 are distinct 
members of the MCM2-3-5 family, P1 being most closely 
related to Mcm3p, and although both MCM2 and MCM3 
genes are essential, there is evidence for genetic interac- 
tions between them (Yan et al., 1991). Like BM28, P1 is a 
phosphoprotein, and the displaced form of the protein ap- 
pears  to  be  hyperphosphorylated  compared  with  the 
bound form. One clear distinction between the behavior of 
the two proteins is that P1 does not appear to be chroma- 
tin associated; perhaps different members of the MCM2-3- 
5 family are associated with different subnuclear domains? 
Replication-mediated Changes in Chromatin and Cell 
Cycle Control 
Both BM28 and its yeast relatives appear to be necessary 
for normal DNA replication, suggesting that the presence 
of BM28 on chromatin may be necessary as a preparation 
for S phase. Onset of DNA synthesis at the G1-S transi- 
tion requires an additional signal, probably involving acti- 
vation of cyclin-dependent kinases (Roberts, 1993).  Since 
Todorov et al. Displacement of  Human Mcm2p during S Phase  1443 BM28 does not colocalize with sites of active DNA repli- 
cation, we speculate that BM28 permits replication, either 
by allowing initiation or passage of a replication fork, but 
that  it  does not  remain  associated  with either  the  repli- 
some or the replicated DNA. Thus, during S phase, the re- 
sidual BM28 staining seen in extracted nuclei could corre- 
spond to unreplicated DNA. Conceivably, the removal of 
BM28  from chromatin  during  replication  could be  rele- 
vant to the mechanism that limits DNA replication to one 
round  per S  phase.  Thus  the  disassembly  of BM28-con- 
taining complexes on replicated DNA during S phase, cou- 
pled with an inability to reassociate BM28 with chromatin 
until the following telophase, could prevent more than one 
round of DNA replication. The function of bound BM28 
could thus be to "flag"  unreplicated DNA.  Studies of the 
S.  cerevisiae  origin-binding  origin  recognition  complex 
have  been  interpreted  to suggest  a similar idea, namely, 
that in late  anaphase  or early telophase,  a prereplicative 
complex may be assembled at replication origins, consist- 
ing of the origin recognition complex and another compo- 
nent, that permits initiation during the later S phase and 
disassembles after replication (Diffley et al., 1994). 
In this context, comparisons can be drawn between the 
properties  predicted  for  licensing  factor  and  those  of 
BM28. Thus, like licensing factor, BM28 could distinguish 
G1  from G2 chromatin, be  required  for replication,  and 
may be in some way inactivated by passage of a replication 
fork.  However,  we  have  no  evidence  that  the  nuclear 
membrane is important for regulating BM28 function, and 
in any case, there is no direct evidence that BM28,  or its 
yeast relatives function as regulatory rather than as neces- 
sary replication components. 
The implication that G1 and G2 chromatin have differ- 
ent protein compositions could have  a  relevance  to pro- 
cesses other than DNA  replication. For instance,  the re- 
striction  of transcription  to particular  phases  of the  cell 
cycle could depend, in part, on transcription factors bound 
to the chromatin template that are displaced by replication 
and cannot rebind until the following G1  phase  (Rita  et 
al., 1991).  This would restrict their period of activity to a 
discrete portion of interphase. In addition, the surveillance 
mechanism that prevents mitosis if S phase is incomplete 
(Hartwell  and  Weinert,  1989;  Enoch  and  Nurse,  1990) 
could  function  in  part  by  monitoring  proteins  that  are 
found on G1 but not G2 chromatin. If proteins associated 
with  G1  chromatin,  normally  displaced  by  replication, 
generated a trans-acting signal that blocked the activation 
of the p34 kinase responsible for the G2 to M  transition, 
this would provide a device to link mitosis to the comple- 
tion of DNA synthesis. 
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